News & Blog

Endpoints News Honors Aspen Neuroscience Co-Founder Dr. Jeanne Loring in “20 Women Breaking New Ground”

Aspen Neuroscience Announces Collaboration and License Agreement with Cell X Technologies

Aspen Neuroscience Chief Financial Officer Kameel Farag to Present at Upcoming Investor Conferences

Aspen Neuroscience Announces Dosing Completion of First Cohort in ASPIRO Phase 1/2a Trial for Parkinson’s Disease

ProJenX and Unlearn Announce Partnership to Augment ALS Clinical Trial PRO-101 with Digital Twin Model

Endpoints News: Stem cell startup spun out of George Church’s lab raises $75M

BioPharma Dive: Startup from George Church’s lab raises $75M to develop ‘supercell’ medicines

FierceBiotech: From ‘science fiction to reality’: New George Church-founded biotech raises $75M for cell therapy platform

STAT: A new cell therapy company takes its vision from four founders, and its skin from George Church

GC Therapeutics Launches to Scale and Unlock the Next Generation of Cell Therapy